| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Pds Biotechnology Corp (PDSB) has 0 insiders with recent SEC Form 4 filings, including 15 buys and 2 sells. PDSB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 3, 2016 | Leuthner Brian A | President And CEO | Sell | 7,500 | $10.25 | $76,844.25 | -2.8% | |
| Aug 8, 2016 | Middlekauff W Bradford | Senior VP, GC And Secretary | Buy | 10,000 | $9.48 | $94,792.85 | +101.5% | |
| Aug 1, 2016 | Leuthner Brian A | President And CEO | Sell | 7,500 | $9.54 | $71,581.50 | -2.7% | |
| Mar 11, 2016 | Loughlin James J | Director | Buy | 3,000 | $7.63 | $22,901.43 | +39.0% | |
| Mar 11, 2016 | Healy James | Director | Buy | 541,343 | $7.30 | $3,951,641.50 | +23.4% | |
| Oct 6, 2015 | Einhorn Andrew J. | Chief Financial Officer | Buy | 45,000 | $11.00 | $495,000.00 | +121.8% | |
| Oct 6, 2015 | Loughlin James J | Director | Buy | 7,000 | $11.00 | $77,000.00 | +57.1% | |
| Oct 6, 2015 | Marchio Albert N II | Chief Acct. &Op., Asst. Sec. | Buy | 100 | $11.00 | $1,100.00 | +1.6% | |
| Oct 6, 2015 | Vaish Renu | V.p., Global Reg. Affairs | Buy | 350 | $11.00 | $3,850.00 | New | |
| Oct 6, 2015 | Faleck Herbert J | Chief Medical Officer | Buy | 500 | $11.00 | $5,500.00 | New |